Optometrists in Emeryville, CA Accepting Medicare
7 Optometrists found. Showing 1 - 7
 Clint Quy Tran, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5707 Christie Ave, Powell Street Plaza, Emeryville, CA 94608 Phone: 510-547-8301 Fax: 510-547-3739 |
James T Liu, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1333 Powell St Ste A-104, Emeryville, CA 94608 Phone: 510-350-8183 |
 Bay Bridge Optometry Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1333 Powell St, Suite A-104, Emeryville, CA 94608 Phone: 626-533-3675 |
 Dr. Jessica Lu, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 6363 Christie Ave, Apt 1203, Emeryville, CA 94608 Phone: 909-525-2583 |
Sagar Girish Shah, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 5707 Christie Ave, Emeryville, CA 94608 Phone: 510-547-8301 |
Grace Yan-chee Leong, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 5707 Christie Ave, Powell Street Plaza, Emeryville, CA 94608 Phone: 510-547-8301 Fax: 510-547-3739 |
Patricia Jean Sha, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4 Admiral Dr # B229, Emeryville, CA 94608 Phone: 916-952-8403 |
News Archive
Cardiac and visual degeneration compensated by taurine supplement
Our genome consists of 20,000 genes, all of which may be capable of triggering disease. It is estimated that there are 7,000 unknown genes that cause recessive genetic diseases resulting from mutations in two copies of a gene that have been inherited from each parent.
Traumatic brain injury investigational treatment from BHR Pharma receives EMA orphan medicinal product designation
BHR Pharma, LLC announced today the European Medicines Agency (EMA), responsible for evaluating medicines developed for use in the European Union, granted an orphan medicinal product designation for treating moderate and severe traumatic brain injury (TBI) to its proprietary intravenous progesterone infusion agent, BHR-100. The agent currently is being evaluated as a neuroprotective treatment for severe traumatic brain injury (TBI) in the global, Phase III SyNAPSe® clinical trial.
UCLA-led team validates first standardized protocol for tracking early signs of Alzheimer's disease
After six years of painstaking research, a UCLA-led team has validated the first standardized protocol for measuring one of the earliest signs of Alzheimer's disease - the atrophy of the part of the brain known as the hippocampus.
Non-powder gun-related pediatric eye injuries on the rise in U.S.
Over 3000 children were treated in U.S. emergency departments in 2012 for eye injuries related to paintball guns, airsoft guns, BB guns and pellet guns, which are popular non-powder guns.
› Verified 6 days ago
Physical Therapists
Chiropractors
Optometrists
Audiologists
Podiatrists
Occupational Therapists
Speech-Language Pathologists